Non-alpha IL-2 Mutein: a Cuban hope for cancer
Currently in clinical trials with advanced cancer patients in Havana, this new drug could mark a turning point in immunotherapy ...
Currently in clinical trials with advanced cancer patients in Havana, this new drug could mark a turning point in immunotherapy ...
Patients with this and other inflammatory and autoimmune diseases could benefit from the novel drug developed by Cuban biotechnology.
When Iraida, 69, tripped over the wheelchair of her 94-year-old mother while she was taking care of her, she did ...
OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.